Chemotherapy-induced cognitive impairments: White matter pathologies.

Area of Science:

• Neuroscience
• Oncology
• Toxicology

Background:

• Chemotherapy effectively treats cancer but can cause long-term cognitive disturbances.
• White matter integrity in the brain is vulnerable to chemotherapy's adverse effects.
• Post-chemotherapy, altered white matter morphology and reduced glial cells are observed.

Purpose of the Study:

• To review evidence linking chemotherapy to white matter damage.
• To highlight the impact of chemotherapy on brain structure and cognitive function.
• To emphasize the need for interventions against chemotherapy-induced neurotoxicity.

Main Methods:

• Literature review of studies on chemotherapy effects on brain white matter.
• Analysis of research on post-chemotherapy morphological changes in white matter tracts.
• Examination of studies correlating white matter alterations with cognitive deficits.

Main Results:

• Chemotherapy is associated with white matter fiber damage and altered morphology.
• Reduced oligodendrocytes, demyelination, gliosis, and leukoencephalopathy are linked to chemotherapy.
• These changes correlate with decreased processing speed and IQ.

Conclusions:

• Chemotherapy can induce significant white matter damage in the brain.
• Understanding this relationship is crucial for patient care.
• Behavioral and pharmacological strategies are needed to prevent or reverse chemotherapy-induced brain toxicity.